IM Cannabis (IMCC) Cash from Financing Activities (2020 - 2025)

IM Cannabis' (IMCC) quarterly Cash from Financing Activities came in at -$1.5 million in Q4 2025, down 155.26% year-on-year from $2.8 million in Q4 2024, and down 134.36% quarter-over-quarter from $4.4 million in Q3 2025.

IM Cannabis (IMCC) Cash from Financing Activities (2020 - 2025) Analysis & Trends

IM Cannabis' Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$1.5 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 155.26% year-over-year to -$1.5 million in Q4 2025; TTM through Dec 2025 was $938116.2, a 65.6% decrease from a year earlier, with the FY2025 full-year figure at $821780.9, down 70.59% from the prior year.
  • Cash from Financing Activities slipped to -$1.5 million in Q4 2025 per IMCC's latest filing, from $4.4 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $35.0 million in Q2 2021 and bottomed at -$3.2 million in Q3 2022.
  • The 5-year median for Cash from Financing Activities is $1.2 million (2022), against an average of $2.7 million.
  • Across the five-year window, Cash from Financing Activities tumbled 268.24% in 2022 and surged 10232.79% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $2.2 million in 2021, then sank by 38.36% to $1.4 million in 2022, then slumped by 101.99% to -$27177.8 in 2023, then jumped by 10232.79% to $2.8 million in 2024, then plunged by 155.26% to -$1.5 million in 2025.
  • Per Business Quant, the three latest IMCC Cash from Financing Activities figures stand at -$1.5 million (Q4 2025), $4.4 million (Q3 2025), and $32477.1 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 IM Cannabis 591,792.44 -193,562.09 1.03 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.52 Mn
Dec 31, 2025 -1.52 Mn
Sep 30, 2025 4.43 Mn
Sep 30, 2025 4.43 Mn
Jun 30, 2025 32,477.06
Jun 30, 2025 32,477.06
Mar 31, 2025 -2.00 Mn
Mar 31, 2025 -2.00 Mn
Dec 31, 2024 2.75 Mn
Dec 31, 2024 2.75 Mn
Sep 30, 2024 -487,480.52
Sep 30, 2024 -487,480.52
Jun 30, 2024 1.09 Mn
Jun 30, 2024 1.09 Mn
Mar 31, 2024 -632,280.45
Mar 31, 2024 -632,280.45
Dec 31, 2023 -27,177.81
Dec 31, 2023 -27,177.81
Sep 30, 2023 -912,272.96
Sep 30, 2023 -912,272.96